06.01.2013 Views

Bulletin 2011/31 - European Patent Office

Bulletin 2011/31 - European Patent Office

Bulletin 2011/31 - European Patent Office

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(G01N) I.1(1)<br />

• PROCÉDÉS POUR DÉTERMINER DES<br />

SUBSTANCES ACTIVES DANS DES<br />

CONJUGUÉS PROMÉDICAMENT-PEG-<br />

PROTÉINE AVEC DES AGENTS PEG LIBÉ-<br />

RABLES (DÉPÉGYLATION IN VITRO)<br />

(71) Baxter International Inc., One Baxter Parkway,<br />

Deerfield, IL 60015, US<br />

Baxter Healthcare S.A., Thurgauerstrasse<br />

130, 8152 Glattpark (Opfikon), CH<br />

Nektar Therapeutics, 201 Industrial Road,<br />

San Carlos, CA 94070, US<br />

(72) VARADI, Katalin, A-1230 Vienna, AT<br />

SCHRENK, Gerald, A-1220 Vienna, AT<br />

ROTTENSTEINER, Hanspeter, A-1020<br />

Vienna, AT<br />

TURECEK, Peter, A-3400 Klosterneuburg, AT<br />

WEBER, Alfred, A-1210 Vienna, AT<br />

ANDERLE, Heinz, A-3400 Klosterneuburg,<br />

AT<br />

CULBERTSON, Sean, M., Gurley AL 35758,<br />

US<br />

FANG, Zhihao, Madison AL 35758, US<br />

ZAPPE, Harold, Harvest 35749, US<br />

ZHANG, Ping, Madison AL 35758, US<br />

BOSSARD, Mary, J., Madison AL 35758, US<br />

(74) Alt, Michael, Bird & Bird LLP Pacellistraße<br />

14, 80333 München, DE<br />

G01N 33/542 → (51) G01N 33/53<br />

(51) G01N 33/543 (11) 2 350 659 A2*<br />

(25) En (26) En<br />

(21) 09760069.6 (22) 25.11.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2009/065862 25.11.2009<br />

(87) WO 2010/062935 2010/22 03.06.2010<br />

(88) 03.03.<strong>2011</strong><br />

(30) 26.11.2008 EP 08305846<br />

17.11.2009 US 620100<br />

(54) • NANOPARTIKULÄRE ZELLKULTUROBER-<br />

FLÄCHE<br />

• NANOPARTICULATE CELL CULTURE<br />

SURFACE<br />

• SURFACE DE CULTURE CELLULAIRE<br />

NANOPARTICULAIRE<br />

(71) Corning Incorporated, 1 Riverfront Plaza,<br />

Corning, NY 148<strong>31</strong>, US<br />

(72) BAKER, Wendy, A, Bath, New York 14810,<br />

US<br />

DE LAMBERT, Bertrand, F-91800 Brunoy, FR<br />

HENRY, David, F-91150 Morigny-Champigny,<br />

FR<br />

PETZOLD, Odessa, Elmira, New York 14901,<br />

US<br />

(74) Chantraine, Sylvie Hélène, Cabinet Beau de<br />

Loménie 158, rue de l'Université, 75340<br />

Paris Cedex 07, FR<br />

(51) G01N 33/543 (11) 2 350 660 A1*<br />

C07K 17/00 C12N 15/09<br />

(25) En (26) En<br />

(21) 09822111.2 (22) 23.10.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) JP 2009/068638 23.10.2009<br />

(87) WO 2010/047419 2010/17 29.04.2010<br />

(30) 24.10.2008 JP 2008274852<br />

18.11.2008 JP 2008294527<br />

13.05.2009 JP 2009117080<br />

(54) • IMMOBILISIERUNGSSUBSTRAT UND<br />

VERFAHREN ZU SEINER HERSTELLUNG<br />

• IMMOBILIZATION SUBSTRATE AND<br />

METHOD FOR PRODUCING THE SAME<br />

• SUBSTRAT D'IMMOBILISATION ET SON<br />

PROCÉDÉ DE PRODUCTION<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(71) FUJIFILM Corporation, 26-30, Nishiazabu 2chome<br />

Minato-ku, Tokyo 106-8620, JP<br />

The University of Tokyo, 3-1, Hongo 7chome,<br />

Bunkyo-Ku Tokyo 113-8654, JP<br />

(72) MINAMI, Koichi, Ashigarakami-gun Kanagawa<br />

258-8577, JP<br />

TSUZUKI, Hirohiko, Ashigarakami-gun<br />

Kanagawa 258-8577, JP<br />

UEDA, Hiroshi, Tokyo 113-8654, JP<br />

IHARA, Masaki, Tokyo 113-8654, JP<br />

(74) HOFFMANN EITLE, <strong>Patent</strong>- und Rechtsanwälte<br />

Arabellastraße 4, 81925 München, DE<br />

G01N 33/543 → (51) G01N 33/53<br />

G01N 33/543 → (51) G01N 33/58<br />

(51) G01N 33/564 (11) 2 350 661 A1*<br />

(25) En (26) En<br />

(21) 09756346.4 (22) 26.10.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) GB 2009/051441 26.10.2009<br />

(87) WO 2010/046716 2010/17 29.04.2010<br />

(30) 25.10.2008 GB 0819634<br />

(54) • NEUROLOGISCHE AUTOIMMUNKRANK-<br />

HEITEN<br />

• NEUROLOGICAL AUTOIMMUNE DISOR-<br />

DERS<br />

• TROUBLES NEUROLOGIQUES AUTO-<br />

IMMUNS<br />

(71) Isis Innovation Limited, University of Oxford<br />

Ewert House Ewert Place Summertown,<br />

Oxford 0X2 7SG, GB<br />

(72) VINCENT, Angela, Oxford Oxfordshire OX3<br />

9DS, GB<br />

(74) Atkinson, Jennifer, Barker Brettell LLP 100<br />

Hagley Road, Edgbaston Birmingham B16<br />

8QQ, GB<br />

G01N 33/564 → (51) G01N 33/53<br />

G01N 33/569 → (51) B01L 3/00<br />

(51) G01N 33/573 (11) 2 350 662 A1*<br />

G01N 33/92 G01N 33/68<br />

(25) En (26) En<br />

(21) 09737386.4 (22) 02.10.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) EP 2009/062852 02.10.2009<br />

(87) WO 2010/037860 2010/14 08.04.2010<br />

(30) 03.10.2008 US 102485 P<br />

27.10.2008 PCT/IB2008/055368<br />

(54) • KOMBINATION DER HERZ-KREISLAUF-<br />

RISIKOFAKTOREN SPLA2-AKTIVITÄT UND<br />

OXPL/APOB ZUR DIAGNOSE/PROGNOSE<br />

EINES HERZ-KREISLAUF-LEIDENS/-<br />

EREIGNISSES<br />

• COMBINATION OF SPLA2 ACTIVITY AND<br />

OXPL/APOB CARDIOVASCULAR RISK<br />

FACTORS FOR THE DIAGNOSIS/PROG-<br />

NOSIS OF A CARDIOVASCULAR DISEASE/<br />

EVENT<br />

• COMBINAISON DES FACTEURS DE<br />

RISQUE CARDIOVASCULAIRE OXPL/APOB<br />

ET D'ACTIVITÉ SPLA2 POUR LE DIAG-<br />

NOSTIC/PRONOSTIC D'UNE MALADIE/<br />

D'UN ÉVÉNEMENT CARDIOVASCULAIRE<br />

(71) INSERM - Institut National de la Santé et de<br />

la Recherche Médicale, 101, rue de Tolbiac,<br />

75013 Paris, FR<br />

The Regents of the University of California,<br />

1111 Franklin Street, 5th Floor, Oakland, CA<br />

94607, US<br />

Université Paris Diderot - Paris 7, 5, rue<br />

Thomas Mann, 75205 Paris Cedex 13, FR<br />

265<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>31</strong>/<strong>2011</strong>) 03.08.<strong>2011</strong><br />

(72) MALLAT, Ziad, F-78580 Herbeville, FR<br />

TEDGUI, Alain, F-75015 Paris, FR<br />

TSIMIKAS, Sotirios, San Diego California<br />

92122, US<br />

WITZTUM, Joseph, San Diego California<br />

92120, US<br />

(74) Icosa, 83 avenue Denfert-Rochereau, 75014<br />

Paris, FR<br />

(51) G01N 33/574 (11) 2 350 663 A2*<br />

C07K 16/18 C12Q 1/68<br />

(25) En (26) En<br />

(21) 09797215.2 (22) 21.10.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2009/061506 21.10.2009<br />

(87) WO 2010/048304 2010/17 29.04.2010<br />

(88) 19.08.2010<br />

(30) 21.10.2008 US 107217 P<br />

17.03.2009 US 160929 P<br />

18.03.2009 US 161<strong>31</strong>5 P<br />

(54) • IDENTIFIZIERUNG VON SIGNATURGENEN<br />

IN ZUSAMMENHANG MIT HEPATOZELLU-<br />

LÄREM KARZINOM<br />

• IDENTIFICATION OF SIGNATURE GENES<br />

ASSOCIATED WITH HEPATOCELLULAR<br />

CARCINOMA<br />

• IDENTIFICATION DE GÈNES SIGNATURE<br />

ASSOCIÉS À UN CARCINOME HÉPATO-<br />

CELLULAIRE<br />

(71) Bayer HealthCare LLC, 555 White Plains<br />

Road, Tarrytown, NY 10591, US<br />

(72) PENA, Carol E.A., New York, US<br />

(74) Kilger, Ute, Forrester & Boehmert Pettenkoferstrasse<br />

20-22, 80336 München, DE<br />

(51) G01N 33/574 (11) 2 350 664 A1*<br />

(25) En (26) En<br />

(21) 09822657.4 (22) 21.10.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) US 2009/061541 21.10.2009<br />

(87) WO 2010/048330 2010/17 29.04.2010<br />

(30) 21.10.2008 US 107253 P<br />

26.11.2008 US 118368 P<br />

06.02.2009 US 150700 P<br />

09.02.2009 US 151163 P<br />

21.09.2009 US 244172 P<br />

(54) • BEHANDLUNG VON KREBS ANHAND VON<br />

HYPOXIE-AKTIVIERTEN PRODRUGS<br />

• TREATMENT OF CANCER USING HYPOXIA<br />

ACTIVATED PRODRUGS<br />

• TRAITEMENT DU CANCER À L'AIDE DE<br />

PROMÉDICAMENTS ACTIVÉS PAR L'HY-<br />

POXIE<br />

(71) Threshold Pharmaceuticals, Inc., 1300 Seaport<br />

Boulevard, Suite 500, Redwood City,<br />

California 94063, US<br />

(72) CURD, John G., Burlingame California<br />

94010, US<br />

KROLL, Stewart, Oakland California 94618,<br />

US<br />

MATTEUCCI, Mark, Portola Valley California<br />

94028, US<br />

HART, Charles P., Mountain View California<br />

94040, US<br />

DUAN, Jian-Xin, South San Francisco California<br />

94080, US<br />

(74) Roques, Sarah Elizabeth, J.A. Kemp & Co. 14<br />

South Square Gray's Inn, London WC1R 5JJ,<br />

GB<br />

(51) G01N 33/574 (11) 2 350 665 A1*<br />

(25) En (26) En<br />

(21) 09826660.4 (22) 11.11.2009

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!